SCHEMBL23046692

SCHEMBL23046692

CCN(c1ccc(-c2ccccc2)cc1)c1ccc2c(c1)oc1ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 2/20 0.42
▸ MAPT P10636 6/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ MEN1 O00255 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ HPGD P15428 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ MMP12 P39900 1/20 0.41
▸ MMP13 P45452 1/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TNKS O95271 1/20 0.40
▸ XDH P47989 1/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ IGLV6-57 P01721 3/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ GLA P06280 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27381939 0.94 AHR (0.45) AHRMAPTALDH1A1MEN1KMT2A
SCHEMBL23765087 0.87 PLA2G2A (0.43) AHRMAPTALDH1A1MEN1KMT2A
SCHEMBL24742113 0.85 MMP12 (0.46) AHRMAPTALDH1A1MEN1KMT2A
SCHEMBL22355408 0.84 AHR (0.47) AHRMAPTALDH1A1MEN1KMT2A
SCHEMBL21038433 0.84 AHR (0.47) AHRMAPTALDH1A1MEN1KMT2A
SCHEMBL6374352 0.84 AHR (0.47) AHRMAPTALDH1A1MEN1KMT2A
SCHEMBL24255500 0.84 AHR (0.47) AHRMAPTALDH1A1MEN1KMT2A
SCHEMBL14295470 0.84 AHR (0.47) AHRMAPTALDH1A1MEN1KMT2A
SCHEMBL21128843 0.84 AHR (0.47) AHRMAPTALDH1A1MEN1KMT2A
SCHEMBL17637199 0.84 AHR (0.47) AHRMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10937968-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2021-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10937968-B2 Compound and organic electronic device using the same CHRM1, CHRM2, C1S AHR 188/4885MAPT 4433/4885ALDH1A1 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback